Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments

Author:

Vagima Yaron,Gur David,Erez Noam,Achdout Hagit,Aftalion Moshe,Levy Yinon,Zauberman Ayelet,Tidhar Avital,Gutman Hila,Lazar Shlomi,Israely Tomer,Paran Nir,Melamed Sharon,Brosh-Nissimov Tal,Chitlaru Theodor,Sagi Irit,Mamroud Emanuelle

Abstract

Abstract Various respiratory viral infections in general and seasonal influenza in particular may increase the susceptibility to bacterial infections. Plague caused by Yersinia pestis endangers large populations during outbreaks or bioterrorism attacks. Recommended antibiotic countermeasures include well-established protocols based on animal studies and corroborated by effective treatment of human cases. Until now, prior exposure to viral respiratory infections was not taken into consideration when selecting the appropriate treatment for plague. Here, we show that as late as 25 days after exposure to influenza virus, convalescent mice still exhibited an increased susceptibility to sublethal doses of Y. pestis, presented with aberrant cytokine expression, and impaired neutrophil infiltration in the lungs. Increased levels of M2 alveolar macrophages and type II epithelial cells, as well as induction in metalloproteases expression and collagen and laminin degradation, suggested that the previous viral infection was under resolution, correlating with enhanced susceptibility to plague. Surprisingly, postexposure prophylaxis treatment with the recommended drugs revealed that ciprofloxacin was superior to doxycycline in mice recovering from influenza infection. These results suggest that after an influenza infection, the consequences, such as impaired immunity and lung tissue remodeling and damage, should be considered when treating subsequent Y. pestis exposure.

Funder

IIBR

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Reference71 articles.

1. WHO. Plague – Madagascar. The World Health Organization. https://www.who.int/csr/don/27-november-2017-plague-madagascar/en/ (2017).

2. WHO. Regional Office for Africa. Plague outbreak Madagascar: external situation report 14. Brazzaville, Congo: WHO, 4 December 2017. https://www.cambridge.org/core/journals/epidemiology-and-infection/article/using-evidence-to-inform-response-to-the-2017-plague-outbreak-in-madagascar-a-view-from-the-who-african-regional-office/A10E864926C053916E62BBE64F079294 (2017).

3. Inglesby, T. V. et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefenss. JAMA 283, 2281–2290 (2000).

4. Kool, J. L. Risk of person-to-person transmission of pneumonic plague. Clin. Infect. Dis. 40, 1166–1172. https://doi.org/10.1086/428617 (2005).

5. Pollitzer, R. Plague studies. VIII. Clinical aspects. Bull. World Health Organ. 9, 59–129 (1953).

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3